US Patent Issued to CSL Innovation on July 15 for "Methods of treating or preventing a cardiovascular system complication of sickle cell disease with an anti-G-CSFR antibody" (American, German, Australian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,689, issued on July 15, was assigned to CSL Innovation Pty Ltd (Melbourne, Australia).

"Methods of treating or preventing a cardiovascular system complication of sickle cell disease with an anti-G-CSFR antibody" was invented by Lisa Margareta Lindqvist (Melbourne, Australia), Andreas Gille (King of Prussia, Pa.), Paolo Rossato (Marburg, Germany), Markus Brechmann (Marburg, Germany), John Davis Belcher (Minneapolis) and Gregory M. Vercellotti (Stillwater, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods for treating or preventing or delaying progression or reducing or inhibiting or hindering development o...